Dragon Pharma Testagen 20 MG

IDENTITYCompoundTestagen
ClassificationBioregulator Peptide
Strength20 mg
FormLyophilized Powder
Package2 ml Vial

PEPTIDE PROFILEPeptide TypeTetrapeptide
SequenceLys-Glu-Asp-Gly (KEDG)
Molecular Weight447.4 g/mol
Half-LifeApprox. 24 Hours
Research ClassPituitary Bioregulator

PHARMACOLOGYTargetEndocrine Regulation
ActivityPituitary Axis Research
Hormonal EffectIndirect Regulation
AromatizationNot Reported
Water RetentionNot Reported

STORAGE & PACKAGEBrandDragon Pharma
Package20 mg Lyophilized Vial
StorageRefrigerated Conditions Recommended
ProtectionProtect From Light & Moisture
ReconstitutionProfessional Laboratory Preparation

USAGE PROFILEResearch Duration20-30 Days
AdministrationPeptide Administration Research
Daily Exposure10-20 mg/day Research Range
Vial DurationApproximately 1-2 Weeks
RecoveryHormonal Monitoring Recommended

ADMINISTRATIONRouteResearch Peptide Administration
FrequencyDaily Schedule
Typical TimeMorning Administration
Cycle Length20-30 Days
MonitoringEndocrine Markers

DOSING INFORMATIONResearch Dose10-20 mg/day
Beginner Protocol10 mg/day
Intermediate10-15 mg/day
Advanced Research20 mg/day
Duration20-30 Days

RECOVERY PROFILEPCTNot Applicable
HPTA SuppressionNot Classified
Hormonal SupportMonitoring Required
DiscontinuationObservation Period
Blood TestingRecommended

COMPATIBILITYPeptide ResearchCompatible Research Category
Hormone StudiesEndocrine Research
TrainingRecovery Research Interest
CombinationScientific Evaluation Required
Athlete UseNot Clinically Approved

MECHANISM OF ACTIONStructureShort Synthetic Peptide
Primary AreaPituitary Research
FunctionBioregulatory Signaling
Endocrine AxisHormonal Communication
ResearchCellular Regulation

PHARMACOKINETICSReleaseShort Peptide Activity
Half-Life~24 Hours
MetabolismPeptide Breakdown Pathways
ExposureDaily Administration Research
StabilityLyophilized Storage Form

SAFETY PROFILEHepatotoxicityNot Reported
Blood PressureNot Reported
EstrogenNo Direct Activity Reported
Clinical StatusResearch Compound
MonitoringRequired

CHEMICAL PROFILEFormulaC17H29N5O9
Weight447.4 g/mol
SequenceKEDG
ClassBioregulator Peptide
CASNot Assigned

OVERVIEW

Dragon Pharma Testagen 20 mg is a lyophilized peptide product classified as a bioregulator peptide. Testagen is studied for its relationship with endocrine signaling, pituitary function and hormonal regulation pathways. In bodybuilding science discussions, it is commonly examined as a recovery and hormonal optimization research compound rather than an anabolic steroid.

BENEFITS

Endocrine regulation research
Pituitary axis investigation
Potential recovery pathway research
Peptide signaling studies
Hormonal balance research

POTENTIAL RISKS

Limited human clinical data
Unknown long-term effects
Possible individual reactions
Research compound limitations
Need for scientific monitoring

PERFORMANCE PROFILE

Recovery Research

75%

Hormonal Research

80%

Muscle Support

45%

Fat Loss

40%

Anabolic Activity

20%

CONCLUSION

Dragon Pharma Testagen 20 MG represents a peptide-based bioregulator compound supplied as lyophilized powder in a multi-dose vial format. Unlike anabolic steroids, Testagen does not function through androgen receptor activation and is researched primarily for endocrine signaling pathways.

The compound has attracted interest among bodybuilding and longevity research communities because of its proposed relationship with pituitary and hormonal regulation. However, clinical evidence remains limited and responsible scientific evaluation is required.

Disclaimer

This content is provided for educational and informational purposes only. Testagen is a research compound and is not approved as a human therapeutic medication. It does not replace medical advice, diagnosis or professional healthcare guidance.